# Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency

> **NCT04295733** · — · COMPLETED · sponsor: **Ospedale Policlinico San Martino** · enrollment: 98 (actual)

## Conditions studied

- Acquired Immunodeficiency

## Interventions

- **BIOLOGICAL:** 4CMenB (Bexsero®) vaccine

## Key facts

- **NCT ID:** NCT04295733
- **Lead sponsor:** Ospedale Policlinico San Martino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-06
- **Primary completion:** 2024-01-11
- **Final completion:** 2024-01-11
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2024-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295733, "Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04295733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*